Overview

Drug Use Investigation of Kovaltry in Hemophilia A Patients

Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The objective in this study is collecting post-marketing information on the safety and efficacy of Kovaltry under the routine clinical practice.
Details
Lead Sponsor:
Bayer
Treatments:
Factor VIII